At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ALMS Alumis Inc.
Closed 01-07 16:00:00 EST
17.92
+1.69
+10.41%
盘后18.05
+0.13+0.73%
19:59 EST
High18.57Low16.70Vol9.37M
Open17.39D1 Closing16.23Amplitude11.52%
Mkt Cap1.87BTradable Cap1.45BTotal Shares104.39M
T/O166.06MT/O Rate11.60%Tradable Shares80.76M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Alumis, Micron Technology
Reuters  ·  01-07 23:52
BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Alumis, Micron Technology
Stock Track | Alumis Inc. Soars 11.21% Intraday on Analyst Upgrades and Positive Drug Trial Results
Stock Track  ·  01-07 23:38
Stock Track | Alumis Inc. Soars 11.21% Intraday on Analyst Upgrades and Positive Drug Trial Results
BUZZ-Biopharma firm Alumis extends gains after commencing $175 mln stock offering
Reuters  ·  01-07 22:53
BUZZ-Biopharma firm Alumis extends gains after commencing $175 mln stock offering
Stock Track | Alumis Inc. Soars 5.67% in Pre-Market on Positive Trial Results and Analyst Upgrades
Stock Track  ·  01-07 20:08
Stock Track | Alumis Inc. Soars 5.67% in Pre-Market on Positive Trial Results and Analyst Upgrades
Alumis Inc : Morgan Stanley Raises Target Price to $33 From $22
THOMSON REUTERS  ·  01-07 19:33
Alumis Inc : Morgan Stanley Raises Target Price to $33 From $22
U.S. RESEARCH ROUNDUP-Alphabet, Hershey, Micron Technology
Reuters  ·  01-07 15:55
U.S. RESEARCH ROUNDUP-Alphabet, Hershey, Micron Technology
Sandisk, Alumis, Micron Technology, Ventyx Biosciences, And Western Digital: Why These 5 Stocks Are On Investors' Radars Today
Benzinga_recent_news  ·  01-07 09:45
Sandisk, Alumis, Micron Technology, Ventyx Biosciences, And Western Digital: Why These 5 Stocks Are On Investors' Radars Today
Stock Track | Alumis Inc. Plunges 5.79% Post-Market Following $175 Million Public Stock Offering Announcement
Stock Track  ·  01-07 09:02
Stock Track | Alumis Inc. Plunges 5.79% Post-Market Following $175 Million Public Stock Offering Announcement
Alumis Plans $175 Million Public Stock Offering
MT Newswires Live  ·  01-07 05:28
Alumis Plans $175 Million Public Stock Offering
BRIEF-Alumis Announces Proposed Public Offering of Common Stock
Reuters  ·  01-07 05:15
BRIEF-Alumis Announces Proposed Public Offering of Common Stock
Alumis Is Maintained at Overweight by Wells Fargo
Dow Jones  ·  01-07 04:47
Alumis Is Maintained at Overweight by Wells Fargo
BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin
Reuters  ·  01-06 23:52
BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin
Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday
Benzinga_recent_news  ·  01-06 23:07
Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday
Alumis (ALMS.US) Soars Over 154% at Open on Positive Phase 3 Psoriasis Drug Trial Results
Stock News  ·  01-06 22:47
Alumis (ALMS.US) Soars Over 154% at Open on Positive Phase 3 Psoriasis Drug Trial Results
Stock Track | Alumis Inc. Soars 167.51% in Pre-Market on Positive Phase 3 Psoriasis Drug Results
Stock Track  ·  01-06 22:32
Stock Track | Alumis Inc. Soars 167.51% in Pre-Market on Positive Phase 3 Psoriasis Drug Results
Alumis Shares Jump 155% to $21 After Co's Skin Disease Drug Meets Main Goal of Two Late Stage Trials
THOMSON REUTERS  ·  01-06 22:32
Alumis Shares Jump 155% to $21 After Co's Skin Disease Drug Meets Main Goal of Two Late Stage Trials
BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge
Reuters  ·  01-06 22:12
BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge
Alumis Exec Says Co Believes Envudeucitinib Is "Very Competitive" With Takeda's Zasocitinib - Conf Call
THOMSON REUTERS  ·  01-06 21:32
Alumis Exec Says Co Believes Envudeucitinib Is "Very Competitive" With Takeda's Zasocitinib - Conf Call
Alumis Shares Surge 90% as Its Skin Disease Drug Meets Main Goal in Late-Stage Trials
Reuters  ·  01-06 21:05
Alumis Shares Surge 90% as Its Skin Disease Drug Meets Main Goal in Late-Stage Trials
Stock Track | Alumis Inc. Soars 94.46% in Pre-Market After Positive Phase 3 Psoriasis Drug Results
Stock Track  ·  01-06 21:02
Stock Track | Alumis Inc. Soars 94.46% in Pre-Market After Positive Phase 3 Psoriasis Drug Results

Introduction

Company Name.
Alumis Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--